Find drugs by alphabetical list:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All
Salix Pharmaceuticals Previews Data Slated for Presentation at 61st Annual ... - MarketWatch (press release)
Salix Pharmaceuticals Previews Data Slated for Presentation at 61st Annual ...MarketWatch (press release)The introduction of XIFAXAN 550 mg, the first new therapy approved for HE in 30 years, is providing physicians a much-needed therapy to manage their ...and more��
XIFAXAN 550 mg (Rifaximin) Demonstrates Acute and Sustained Relief of Non ... - MarketWatch (press release)
XIFAXAN 550 mg (Rifaximin) Demonstrates Acute and Sustained Relief of Non ...MarketWatch (press release)A significantly higher percentage of XIFAXAN 550 mg-treated patients responded favorably for each endpoint, compared with placebo, within each study," said ...Salix Reports Positive Results From Study Of Xifaxan In Non-C IBS - UpdateStock Markets Reviewall 21 news articles��
Salix says FDA to take longer Xifaxan review - BusinessWeek
Salix says FDA to take longer Xifaxan reviewBusinessWeekSalix Pharmaceuticals Ltd. said Monday the Food and Drug Administration will take three additional months to review the company's application for Xifaxan as ...FDA extends Salix drug review three monthsLocal Tech Wire (blog)FDA Extends Salix Pharma's (SLXP) PDUFA Goal Date for XIFAXANStreetInsider.com (subscription)FDA Extends Salix Pharma's XIFAXAN SNDA PDUFA Goal Date To March 7, 2011 ...RTT NewsTriangle Business Journalall 20 news articles��
ACG 2010 Annual Meeting Highlights - About - News & Issues
ACG 2010 Annual Meeting HighlightsAbout - News & IssuesOf all of the material presented, here are some highlights with relevance for IBS: Xifaxan successful in treating non-constipated IBS: Salix Pharmaceuticals ...
Last updated on: Jan 24, 2007
Brand Name: | Xifaxan |
Active Ingredient: | Rifaximin |
Strength(s): | 200 mg |
Dosage Form(s): | Tablet |
Company Name: | Salix Pharmaceuticals |
Availability: | Prescription only |
*Date Approved by FDA: | May 25, 2004 |
*Approval by FDA does not mean that the drug is available for consumers at this time.
This information is provided by the U.S. Food & Drug Administration.
For more information about this drug, click here. |
What is Xifaxan used for?
Xifaxan is a nonsystemic (does not get into your bloodstream) antibiotic used to treat diarrhea caused by eating food or drinking fluids that have been contaminated with germs called bacteria.
Who should not take Xifaxan?
Special Warning(s) with Xifaxan:
Sometimes viruses rather than bacteria may cause diarrhea. Xifaxan, like all other antibiotics, does not kill viruses. You should contact your doctor or health care professional if you think your condition is getting worse or is not improving after 24 - 48 hours (1 - 2 days) while taking Xifaxan.
What should I tell my health care provider?
Tell your health care provider if you are pregnant, are trying to become pregnant, or are breast-feeding.
Xifaxan has not been shown to cause interactions with other drugs. However, it is always important that you inform your doctor or healthcare professional of any other medications you are taking before starting treatment with Xifaxan.
What are some possible side effects of Xifaxan? (This list is NOT a complete list of side effects reported with Xifaxan. Your health care provider can discuss with you a more complete list of side effects.)
Some common side effects with Xifaxan include:
Accupril
Actonel
Actos
Allegra
Altace
Atenolol
Avandia
Celebrex
Celexa
Cialis
Coreg
Cozaar
Crestor
Diovan
Effexor
Evista
Flomax
Fluoxetine
Fosamax
Glucophage
Latisse
Levitra
Levoxyl
Lexapro
Lipitor
Lisinopril
Metformin
Neurontin
Nexium
Norvasc
Paxil
Plavix
Pravachol
Premarin
Prevacid
Prilosec
Propecia
Protonix
Prozac
Seroquel
Simvastatin
Singulair
Toprol-XL
Viagra
Zetia
Zithromax
Zocor
Zoloft
Zyprexa
Zyrtec